Navigation Links
China Sky One Medical Completes Previously Announced Amendments to Form 10QSB for the Second and Third Quarters of 2006
Date:12/19/2007

HARBIN, China, Dec. 19 /Xinhua-PRNewswire-FirstCall/ -- China Sky One Medical, Inc. (OTC Bullion Board: CSKI), a manufacturer, marketer and distributor of pharmaceutical, medicinal and diagnostic products in China, today announced that it has filed the previously announced amendments to the Company's Form 10QSB for the fiscal quarters ended June 30, 2006 and September 30, 2006. The Company filed its full year 2006 amendments on November 8, 2006. Today's amendments complete the Company's obligation to amend its numbers for the fiscal year 2006 and do not impact financial results reported in the year 2007.

On November 8, 2007, the Company explained that net income for the year 2006 was adjusted to account for $3.67 million of costs that were incorrectly treated, including roughly $1.8 million of one-time costs related to the Company's 2006 recapitalization, as well as approximately $1.8 million of capitalized research and development costs which should have been charged to operations when incurred. As such, full year 2006 net income was adjusted to $630,000 from $4.3 million.

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company whose principal operations are through its subsidiaries, which are engaged in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic kit products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR") and Harbin First Bio- Engineering Company Limited ("First"), the Company's principal revenue source is the manufacture and sale of over-the-counter pharmaceutical products.

http://www.skyonemedical.com

Safe Harbor Statement

Certain of the statements made in the press release constitute forward- looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements ca
'/>"/>

SOURCE China Sky One Medical, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2008)...y 21 /PRNewswire-FirstCall/ -- Aflac Incorporated,...presentation at the Sanford,C. Bernstein & Co., LL...nce,2008., President and Chief Financial Officer ...ted, and he is scheduled to make a presentation on...orated presentation, Mr.,Cloninger will discuss th...
(Date:5/21/2008)...d SILVER SPRING, Md., May 21 /PRNewswire-USNewswir... (ADAA),( http://www.adaa.org ) and The HealthCent... announced that ADAA will join,HealthCentral,s gro...and,health experts dedicated to helping people suf... advice and support they need to cope with the,con...
(Date:5/21/2008)...s 1st quarter profit, enhanced operations and new ...ELES, May 21 /PRNewswire-FirstCall/ -- InstaCare C...butor of at-home testing diagnostics,for the chron...eveloper of,patent-pending technologies for e-heal...s for the first quarter period-ended March 31, 200...
(Date:5/21/2008)... Adverse Events in TORCH Showed Frequency Highest ...ONTO and RESEARCH TRIANGLE PARK, N.C., May 21 /PRN...500/50 (fluticasone propionate and,salmeterol inha...er of,cardiovascular adverse events compared to ot...from the TOwards a Revolution in COPD Health,(TORC...
Breaking Medicine News(10 mins):Health News:Aflac Incorporated to Present at the Sanford C. Bernstein & Co., LLC Twenty-Fourth Annual Strategic Decisions Conference 2008 2Health News:The Anxiety Disorders Association of America and The HealthCentral Network Form Alliance to Develop New Online Resources for Anxiety Disorders 2Health News:The Anxiety Disorders Association of America and The HealthCentral Network Form Alliance to Develop New Online Resources for Anxiety Disorders 3Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 2Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 3Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 4Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 5Health News:Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50 2Health News:Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50 3
...lls, and AIDS/HIV is also one of them. It is obser...ed till the secondary levels show a// tendency to ...jumping at the first opportunity. The educated lot...rotected sex, according to a novel report on HIV. ...
...en on weight loss programmes, aspiring to melt awa...lulite is extremely obstinate// and never really g...New research has indicated that when women knock o...te actually makes the skin look worse. Cellulite h...
... share many characteristics with normal stem cells...oting tumor blood vessel// formation, and may hold...rch team reported in the August 15th issue of Canc..., associate professor at the Preston Robert Tisch ...
... University published his findings on a better sub..., this month//. According to peer-reviewed researc...it the kind of immune response doctors were lookin...esting, the vaccine was given to 100 volunteers at...
Other Medicine News:Health News:Cancer Stem Cells Could Hold Key to Brain Tumor Therapy 2
(Date:5/21/2008)...ark Laboratories, L.C., a,privately-owned biopharm...of enrollment into its Phase II clinical trial to ...n combination with standard of care therapy in,U.S... have previously,failed to respond to the standard...e company expects to announce interim data results...
(Date:5/21/2008)...oup of Leading Cancer Centers ...y 21 /- Endocare, Inc.,(Nas... focused on the,development of minimally invasive ... radiologists for tissue and tumor ablation, annou... method of freezing cancerous tumors,to destroy th...
(Date:5/20/2008)...positive results of nine month,PAINT trials for Dr...esults unveiled during plenary session of Eu...wswire/ -- Sahajanand Medical Technologies,Pvt. Lt...facturer of,drug-eluting stents, welcomed the posi...onths results of PAINT trial (PercutAneous INTerve...
(Date:5/20/2008)...igestive Disease Week -, CAMBRIDGE, Mass. and NEW...harmaceuticals, Inc. (formerly Microbia, Inc.) and...ounced the presentation of data,from a Phase 2b ra...ssessing the safety and efficacy of linaclotide in... of these data indicate that linaclotide met its,p...
Breaking Medicine Technology:Romark Laboratories Completes Enrollment in U.S. Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non-Responders 2Romark Laboratories Completes Enrollment in U.S. Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non-Responders 3Cryoablation Is Focus of 17 Clinical Studies at American Urological Association Annual Meeting 2Cryoablation Is Focus of 17 Clinical Studies at American Urological Association Annual Meeting 3Cryoablation Is Focus of 17 Clinical Studies at American Urological Association Annual Meeting 4Sahajanand Medical Technologies PAINT Trial Results Support Safety and Efficacy of the Infinnium and Supralimus Stents 2Sahajanand Medical Technologies PAINT Trial Results Support Safety and Efficacy of the Infinnium and Supralimus Stents 3Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 2Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 3Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 4Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 5Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 6Secondhand smoke increases teen test failure 1648 1Secondhand smoke increases teen test failure 1648 2Spectral partner launches EAA 28TM 29 Rapid Sepsis Diagnostic in Germany 711 1Spectral partner launches EAA 28TM 29 Rapid Sepsis Diagnostic in Germany 711 2Vical Licensee Sanofi aventis Initiates Phase 3 Trial to Reduce Amputations 336 1Vical Licensee Sanofi aventis Initiates Phase 3 Trial to Reduce Amputations 336 2Vical Licensee Sanofi aventis Initiates Phase 3 Trial to Reduce Amputations 336 3MedAire to Provide Medical Training for Bombardier Safety Standdown 1644 1MedAire to Provide Medical Training for Bombardier Safety Standdown 1644 2MedAire to Provide Medical Training for Bombardier Safety Standdown 1644 3
...ylene Glycol,(DEG) Remains a Potential Health Haza...he U.S. Food and Drug,Administration (FDA) is warn...repackers, and health professionals who compound,m...hat glycerin, a,sweetener commonly used worldwide ...roducts, is not contaminated with diethylene,glyco...
...nnovations and a Health Conscious,Public?, WASHING... Food,and Drug Administration (FDA) must adapt to ...lthcare, Commissioner Andrew von,Eschenbach told a...,Annual Conference April 12 in Bethesda, Md. , FDA...ited,financial and personnel resources to deal wit...
Other Medicine Technology:FDA Advises Manufacturers to Test Glycerin for Possible,Contamination 2FDLI 50th Annual Meeting Heralds New ERA in Healthcare Innovations,FDA Regulations 2
Cushing bayonet forceps. Insulated.
Scleral blades designed for trabeculectomy and groove type incisions, scleral standard USA size.
Accurately tests for Nystagmus when rotated at 8-10 rpm. Drums are 10" high by 8" diameter. Light weight drum of professional quality with ball bearings for effortless spin mechanism. For use 24 to 3
Diagnose dry eye, assess the effectiveness of permanent punctal occlusion, collagen - dissolvable in 3-5 days, all are 2 mm long. Sterile
Medicine Products: